KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMD) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for LifeMD (LFMD) over the last 11 years, with Q3 2025 value amounting to $28.6 million.

  • LifeMD's Other Operating Expenses rose 1774.43% to $28.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $95.1 million, marking a year-over-year increase of 360.14%. This contributed to the annual value of $86.5 million for FY2024, which is 3157.3% up from last year.
  • As of Q3 2025, LifeMD's Other Operating Expenses stood at $28.6 million, which was up 1774.43% from $24.5 million recorded in Q2 2025.
  • LifeMD's 5-year Other Operating Expenses high stood at $28.6 million for Q3 2025, and its period low was -$248000.0 during Q3 2022.
  • Its 5-year average for Other Operating Expenses is $20.7 million, with a median of $23.5 million in 2023.
  • As far as peak fluctuations go, LifeMD's Other Operating Expenses tumbled by 10114.72% in 2022, and later soared by 957789.76% in 2023.
  • Quarter analysis of 5 years shows LifeMD's Other Operating Expenses stood at $23.9 million in 2021, then rose by 1.17% to $24.2 million in 2022, then decreased by 0.4% to $24.1 million in 2023, then plummeted by 34.89% to $15.7 million in 2024, then skyrocketed by 82.21% to $28.6 million in 2025.
  • Its last three reported values are $28.6 million in Q3 2025, $24.5 million for Q2 2025, and $26.3 million during Q1 2025.